XML 54 R34.htm IDEA: XBRL DOCUMENT
v3.24.1

Consolidated Statements of Operations and Comprehensive Loss (Details) - Schedule of Weighted Average | 12 Months Ended
--- | ---
Dec. 31, 2023 € / shares shares | Dec. 31, 2023 $ / shares shares | Dec. 31, 2022 € / shares shares | Dec. 31, 2022 $ / shares shares | Dec. 31, 2021 € / shares shares | Dec. 31, 2021 $ / shares shares
2021 |  |  |  |  |  |
Options (in Shares) | shares | 1,735,750 | 1,735,750 | 1,966,666 | 1,966,666 | 1,219,074 | 1,219,074
January 4 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares |  |  |  |  | 839,260 | 839,260
Fair value per option |  |  |  |  |  | $ 4.53
FX rate as of grant date |  |  |  |  |  | $ 0.8133
Fair value per option (in Euro per share) | € / shares |  |  |  |  | € 3.68 |
Expected volatility |  |  |  |  | 1.35% | 1.35%
Expected life (midpoint based) |  |  |  |  | 5 years 3 months 21 days | 5 years 3 months 21 days
Risk-free rate (interpolated, U.S. sovereign strips curve) |  |  |  |  | 0.50% | 0.50%
January 4 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Share price at grant date / Exercise price |  |  |  |  |  | $ 5.14
January 4 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares |  |  |  |  | 31,668 | 31,668
Fair value per option |  |  |  |  |  | $ 4.57
FX rate as of grant date |  |  |  |  |  | $ 0.8133
Fair value per option (in Euro per share) | € / shares |  |  |  |  | € 3.72 |
Expected volatility |  |  |  |  | 1.35% | 1.35%
Expected life (midpoint based) |  |  |  |  | 5 years 6 months | 5 years 6 months
Risk-free rate (interpolated, U.S. sovereign strips curve) |  |  |  |  | 0.50% | 0.50%
January 4 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Share price at grant date / Exercise price |  |  |  |  |  | $ 5.14
July 2 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares |  |  |  |  | 327,436 | 327,436
Fair value per option |  |  |  |  |  | $ 2.64
FX rate as of grant date |  |  |  |  |  | $ 0.8458
Fair value per option (in Euro per share) | € / shares |  |  |  |  | € 2.23 |
Expected volatility |  |  |  |  | 1.35% | 1.35%
Expected life (midpoint based) |  |  |  |  | 5 years 3 months 21 days | 5 years 3 months 21 days
Risk-free rate (interpolated, U.S. sovereign strips curve) |  |  |  |  | 0.98% | 0.98%
July 2 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Share price at grant date / Exercise price |  |  |  |  |  | $ 2.99
July 2 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares |  |  |  |  | 20,710 | 20,710
Fair value per option |  |  |  |  |  | $ 2.66
FX rate as of grant date |  |  |  |  |  | $ 0.8458
Fair value per option (in Euro per share) | € / shares |  |  |  |  | € 2.25 |
Expected volatility |  |  |  |  | 1.35% | 1.35%
Expected life (midpoint based) |  |  |  |  | 5 years 5 months 26 days | 5 years 5 months 26 days
Risk-free rate (interpolated, U.S. sovereign strips curve) |  |  |  |  | 1.01% | 1.01%
July 2 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Share price at grant date / Exercise price |  |  |  |  |  | $ 2.99
January 12 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares |  |  | 1,516,666 | 1,516,666 |  |
Fair value per option |  |  |  | $ 3.66 |  |
FX rate as of grant date |  |  |  | $ 0.8795 |  |
Fair value per option (in Euro per share) | € / shares |  |  | € 3.22 |  |  |
Expected volatility |  |  | 1.35% | 1.35% |  |
Expected life (midpoint based) |  |  | 5 years 3 months 21 days | 5 years 3 months 21 days |  |
Risk-free rate (interpolated, U.S. sovereign strips curve) |  |  | 1.57% | 1.57% |  |
January 12 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Share price at grant date / Exercise price |  |  |  | $ 4.13 |  |
January 12 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares |  |  | 45,000 | 45,000 |  |
Fair value per option |  |  |  | $ 3.68 |  |
FX rate as of grant date |  |  |  | $ 0.8795 |  |
Fair value per option (in Euro per share) | € / shares |  |  | € 3.24 |  |  |
Expected volatility |  |  | 1.35% | 1.35% |  |
Expected life (midpoint based) |  |  | 5 years 6 months | 5 years 6 months |  |
Risk-free rate (interpolated, U.S. sovereign strips curve) |  |  | 1.59% | 1.59% |  |
January 12 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Share price at grant date / Exercise price |  |  |  | $ 4.13 |  |
Repricing, April 13 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares |  |  |  |  |  |
FX rate as of grant date |  |  |  | $ 0.9237 |  |
Expected volatility |  |  | 1.35% | 1.35% |  |
Risk-free rate (interpolated, U.S. sovereign strips curve) |  |  | 2.60% | 2.60% |  |
Repricing, April 13 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Fair value per option |  |  |  | $ 1.2 |  |
Fair value per option (in Euro per share) | € / shares |  |  | € 1.11 |  |  |
Share price at grant date / Exercise price |  |  |  | $ 1.86 |  |
Expected life (midpoint based) |  |  | 1 year 9 months 29 days | 1 year 9 months 29 days |  |
Repricing, April 13 [Member] | Top of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Fair value per option |  |  |  | $ 1.63 |  |
Fair value per option (in Euro per share) | € / shares |  |  | € 1.5 |  |  |
Expected life (midpoint based) |  |  | 4 years 11 months 8 days | 4 years 11 months 8 days |  |
November 21 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares |  |  | 405,000 | 405,000 |  |
Fair value per option |  |  |  | $ 2.04 |  |
FX rate as of grant date |  |  |  | $ 0.976 |  |
Fair value per option (in Euro per share) | € / shares |  |  | € 1.99 |  |  |
Expected volatility |  |  | 1.35% | 1.35% |  |
Expected life (midpoint based) |  |  | 4 years | 4 years |  |
Risk-free rate (interpolated, U.S. sovereign strips curve) |  |  | 4.15% | 4.15% |  |
November 21 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Share price at grant date / Exercise price |  |  |  | $ 2.44 |  |
January 24 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares | 1,454,250 | 1,454,250 |  |  |  |
Fair value per option |  | $ 2.11 |  |  |  |
FX rate as of grant date |  | $ 0.9008 |  |  |  |
Fair value per option (in Euro per share) | € / shares | € 1.9 |  |  |  |  |
Expected volatility | 1.35% | 1.35% |  |  |  |
Expected life (midpoint based) | 5 years 3 months 18 days | 5 years 3 months 18 days |  |  |  |
Risk-free rate (interpolated, U.S. sovereign strips curve) | 3.571% | 3.571% |  |  |  |
January 24 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Share price at grant date / Exercise price |  | $ 2.37 |  |  |  |
January 24 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares | 52,500 | 52,500 |  |  |  |
Fair value per option |  | $ 2.13 |  |  |  |
FX rate as of grant date |  | $ 0.9008 |  |  |  |
Fair value per option (in Euro per share) | € / shares | € 1.92 |  |  |  |  |
Expected volatility | 1.35% | 1.35% |  |  |  |
Expected life (midpoint based) | 5 years 6 months | 5 years 6 months |  |  |  |
Risk-free rate (interpolated, U.S. sovereign strips curve) | 3.565% | 3.565% |  |  |  |
January 24 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Share price at grant date / Exercise price |  | $ 2.37 |  |  |  |
May 31 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares | 60,500 | 60,500 |  |  |  |
Fair value per option |  | $ 3.61 |  |  |  |
FX rate as of grant date |  | $ 0.9361 |  |  |  |
Fair value per option (in Euro per share) | € / shares | € 3.38 |  |  |  |  |
Expected volatility | 1.35% | 1.35% |  |  |  |
Expected life (midpoint based) | 4 years 6 months | 4 years 6 months |  |  |  |
Risk-free rate (interpolated, U.S. sovereign strips curve) | 3.82% | 3.82% |  |  |  |
May 31 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Share price at grant date / Exercise price |  | $ 4.19 |  |  |  |
July 7 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares | 57,000 | 57,000 |  |  |  |
Fair value per option |  | $ 3.59 |  |  |  |
FX rate as of grant date |  | $ 0.9184 |  |  |  |
Fair value per option (in Euro per share) | € / shares | € 3.3 |  |  |  |  |
Expected volatility | 1.46% | 1.46% |  |  |  |
Expected life (midpoint based) | 5 years 6 months | 5 years 6 months |  |  |  |
Risk-free rate (interpolated, U.S. sovereign strips curve) | 4.32% | 4.32% |  |  |  |
July 7 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Share price at grant date / Exercise price |  | $ 3.89 |  |  |  |
July 7 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares | 100,000 | 100,000 |  |  |  |
Fair value per option |  | $ 3.64 |  |  |  |
FX rate as of grant date |  | $ 0.9184 |  |  |  |
Fair value per option (in Euro per share) | € / shares | € 3.34 |  |  |  |  |
Expected volatility | 1.46% | 1.46% |  |  |  |
Expected life (midpoint based) | 6 years 1 month 6 days | 6 years 1 month 6 days |  |  |  |
Risk-free rate (interpolated, U.S. sovereign strips curve) | 4.286% | 4.286% |  |  |  |
July 7 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Share price at grant date / Exercise price |  | $ 3.89 |  |  |  |
July 19 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares | 4,000 | 4,000 |  |  |  |
Fair value per option |  | $ 3.55 |  |  |  |
FX rate as of grant date |  | $ 0.8911 |  |  |  |
Fair value per option (in Euro per share) | € / shares | € 3.16 |  |  |  |  |
Expected volatility | 1.46% | 1.46% |  |  |  |
Expected life (midpoint based) | 5 years 6 months | 5 years 6 months |  |  |  |
Risk-free rate (interpolated, U.S. sovereign strips curve) | 4.32% | 4.32% |  |  |  |
July 19 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Share price at grant date / Exercise price |  | $ 3.99 |  |  |  |
September 18 [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Options (in Shares) | shares | 7,500 | 7,500 |  |  |  |
Fair value per option |  | $ 3.15 |  |  |  |
FX rate as of grant date |  | $ 0.9378 |  |  |  |
Fair value per option (in Euro per share) | € / shares | € 2.95 |  |  |  |  |
Expected volatility | 1.46% | 1.46% |  |  |  |
Expected life (midpoint based) | 5 years 6 months | 5 years 6 months |  |  |  |
Risk-free rate (interpolated, U.S. sovereign strips curve) | 4.32% | 4.32% |  |  |  |
September 18 [Member] | Bottom of range [Member] |  |  |  |  |  |
2021 |  |  |  |  |  |
Share price at grant date / Exercise price |  | $ 3.54 |  |  |  |

X
- Definition The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The fair value option per share. + References No definition available. + Details
Name: | ifrx_FairValuePerOptions
Namespace Prefix: | ifrx_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The fair value per option. + References No definition available. + Details
Name: | ifrx_FairValuesPerOptions
Namespace Prefix: | ifrx_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The foreign exchange rate as grant date. + References No definition available. + Details
Name: | ifrx_ForeignExchangeRateAsOfGrantDate
Namespace Prefix: | ifrx_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share options granted options. + References No definition available. + Details
Name: | ifrx_ShareOptionsGrantedOptions
Namespace Prefix: | ifrx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The share price at grant date and exercise price. + References No definition available. + Details
Name: | ifrx_SharePriceAtGrantDateExercisePrices
Namespace Prefix: | ifrx_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrx_a2021Abstract
Namespace Prefix: | ifrx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_January4Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_January4OneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_July2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_July2OneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_January12Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_January12OneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_RepricingApril13Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_November21Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JanuaryTwentyFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JanuaryTwentyFourOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_MayThirtyOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JulySevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JulySevenOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_JulyNineteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CumulativeEffectAtDateOfInitialApplicationAxis=ifrx_SeptemberEighteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |